Exercise price per share or per unit of warrants or rights outstanding.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.

+ References

+ Details

Name:	us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The percentage of ownership of common stock or equity participation in the investee accounted for under the equity method of accounting.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 323
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Subparagraph (a)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481687/323-10-50-3

+ Details

Name:	us-gaap_EquityMethodInvestmentOwnershipPercentage
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Topic 310
-SubTopic 10
-Name Accounting Standards Codification
-Section 45
-Paragraph 13
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481990/310-10-45-13

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(i))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(c)(2)(ii))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(g)(3))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

+ Details

Name:	us-gaap_RelatedPartyTransactionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Cash received on stock transaction after deduction of issuance costs.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Amount of consideration received by subsidiary or equity investee in exchange for shares of stock issued or sold. Includes amount of cash received, fair value of noncash assets received, and fair value of liabilities assumed by the investor.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockConsiderationReceivedPerTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Price of a single share of a number of saleable stocks of a company.

+ References

No definition available.

+ Details

Name:	us-gaap_SharePrice
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Per share or per unit amount of equity securities issued.

+ References

No definition available.

+ Details

Name:	us-gaap_SharesIssuedPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis=crvs_AngelPharmaceuticalsLtdEquityMethodInvesteeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_OtherAdditionalCapitalMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=crvs_CommonStockSharesAndCommonStockWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=crvs_PrefundedWarrantsAndCommonStockWarrantsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_InvestorMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=crvs_PeterThompsonMdBoardOfDirectorsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_OtherAffiliatesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=crvs_TedWangPhdDirectorOfAngelPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ChiefExecutiveOfficerMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_ExecutiveVicePresidentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Related Party Transactions - Registered Direct Offering (Details) - USD ($)	May 06, 2024	Dec. 31, 2024	Oct. 31, 2020
Related Party Transaction [Line Items]
Purchase price of warrants		$ 5.35
Angel Pharmaceuticals, Ltd
Related Party Transaction [Line Items]
Corvus Pharmaceuticals equity ownership in subsidiary		49.70%	53.20%
Registered Direct Offering
Related Party Transaction [Line Items]
Gross proceeds from sale of stock	$ 30,600,000
Registered Direct Offering \| Common Warrants
Related Party Transaction [Line Items]
Exercise price of warrants	$ 3.5
Registered Direct Offering \| Pre-funded Warrants
Related Party Transaction [Line Items]
Exercise price of warrants	0.0001
Purchase price of warrants	3.4999
Registered Direct Offering \| Common Stock and Common Warrants
Related Party Transaction [Line Items]
Combined offering price per share	$ 1.7312
Registered Direct Offering \| Common Stock and Common Warrants \| Common Stock
Related Party Transaction [Line Items]
Shares issued in transaction	13,512,699
Registered Direct Offering \| Common Stock and Common Warrants \| Common Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	13,078,509
Registered Direct Offering \| Pre-funded and Common Warrants
Related Party Transaction [Line Items]
Combined offering price per share	$ 1.7311
Registered Direct Offering \| Pre-funded and Common Warrants \| Common Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	4,010,927
Registered Direct Offering \| Pre-funded and Common Warrants \| Pre-funded Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	4,144,085
OrbiMed Advisors LLC (1) \| Peter Thompson, MD \| Registered Direct Offering \| Pre-funded and Common Warrants
Related Party Transaction [Line Items]
Aggregate purchase price	$ 2,499,856
OrbiMed Advisors LLC (1) \| Peter Thompson, MD \| Registered Direct Offering \| Pre-funded and Common Warrants \| Common Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	1,397,684
OrbiMed Advisors LLC (1) \| Peter Thompson, MD \| Registered Direct Offering \| Pre-funded and Common Warrants \| Pre-funded Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	1,444,085
Puissance Capital Management (2) \| Ted Wang, PhD \| Angel Pharmaceuticals, Ltd
Related Party Transaction [Line Items]
Corvus Pharmaceuticals equity ownership in subsidiary	49.70%
Puissance Capital Management (2) \| Ted Wang, PhD \| Registered Direct Offering \| Common Stock and Common Warrants
Related Party Transaction [Line Items]
Aggregate purchase price	$ 1,500,000
Puissance Capital Management (2) \| Ted Wang, PhD \| Registered Direct Offering \| Common Stock and Common Warrants \| Common Stock
Related Party Transaction [Line Items]
Shares issued in transaction	866,451
Puissance Capital Management (2) \| Ted Wang, PhD \| Registered Direct Offering \| Common Stock and Common Warrants \| Common Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	838,610
Richard A. Miller, MD (3) \| Registered Direct Offering \| Common Stock and Common Warrants
Related Party Transaction [Line Items]
Aggregate purchase price	$ 1,000,000
Richard A. Miller, MD (3) \| Registered Direct Offering \| Common Stock and Common Warrants \| Common Stock
Related Party Transaction [Line Items]
Shares issued in transaction	577,634
Richard A. Miller, MD (3) \| Registered Direct Offering \| Common Stock and Common Warrants \| Common Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	559,073
William B. Jones, PhD (4) \| Registered Direct Offering \| Common Stock and Common Warrants
Related Party Transaction [Line Items]
Aggregate purchase price	$ 34,624
William B. Jones, PhD (4) \| Registered Direct Offering \| Common Stock and Common Warrants \| Common Stock
Related Party Transaction [Line Items]
Shares issued in transaction	20,001
William B. Jones, PhD (4) \| Registered Direct Offering \| Common Stock and Common Warrants \| Common Warrants
Related Party Transaction [Line Items]
Warrants issued to purchase common shares	19,358